PATENT CLAIM ANALYSIS

Application Number: 15956941
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-10
Patent Classification: ["514", "015100"]

Abstract:
The invention provides a method for reducing oxidative damage in a mammal, a removed organ, or a cell in need thereof. The method comprises administering an effective amount of an aromatic cationic peptide. The aromatic cationic peptide has (a) at least one net positive charge; (b) a minimum of three amino acids; (c) a maximum of about twenty amino acids, (d) a relationship between the minimum number of net positive charges (p m ) and the total number of amino acid residues (r) wherein 3 p m  is the largest number that is less than or equal to r+1; (e) a relationship between the minimum number of aromatic groups (a) and the total number of net positive charges (p t ) wherein 3a or 2a is the largest number that is less than or equal to p t +1, except that when a is 1, p t  may also be 1; and (f) at least one tyrosine or tryptophan amino acid.

Claim (Index 4):
The method of  claim 1 , wherein the peptide is mixed with a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 91.0
- Lexical Diversity: 2.24706
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12843333', '11428188', '11040242', '14955412', '14100626']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8216916365105283
- 35 USC 102 Novelty (BERT): 0.6444709628016112
- Combined Prediction Score: 0.8039695691396366
- Mean Citation Score: 589.279242
- Max Citation Score: 593.7151
- Similarity Product: 584.4971521019042

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test